Synthesis of substituted triazolyl curcumin mimics that inhibit RANKL-induced osteoclastogenesis

Authors
Park, Sang-KyuOh, SangtaeShin, Hye KyoungKim, Seong HwanHam, JungyeobSong, Jae-SeokLee, Seokjoon
Issue Date
2011-06-15
Publisher
Pergamon Press Ltd.
Citation
Bioorganic & Medicinal Chemistry Letters, v.21, no.12, pp.3573 - 3577
Abstract
Some promising new antiresorptive agents of potential utility for treating osteoporosis were uncovered in a curcumin mimics library possessing a substituted triazole moiety, which is synthesized by the Cu(I)-catalyzed Huisgen 1,3-cycloaddition reaction between two azido intermediates (9 and 10) and various alkynes (a-k). A tartarate-resistant acid phosphatase (TRAP) activity assay was carried out with RANKL-induced osteoclastogenesis of mouse monocyte/macrophage RAW264.7 cells; the results indicated that the curcumin mimics derived from intermediate 10 exhibited stronger inhibitory activity than 9. In particular, curcumin mimics 12h, 13c, and 13e strongly inhibited osteoclast differentiation. (C) 2011 Elsevier Ltd. All rights reserved.
Keywords
MULTIDRUG-RESISTANCE; MINERAL DENSITY; BONE; RECEPTOR; OSTEOPOROSIS; REVERSAL; MULTIDRUG-RESISTANCE; MINERAL DENSITY; BONE; RECEPTOR; OSTEOPOROSIS; REVERSAL; triazolyl curcumin; inhibitor; RANKL-induced; osteoclastogenesis
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/130258
DOI
10.1016/j.bmcl.2011.04.106
Appears in Collections:
KIST Article > 2011
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE